Dangers of Environmental Tobacco Smoke (ETS) exposure
Epidemiology of Childhood Smoking
Factors associated with youth tobacco use
Quick Guide to Tobacco Pharmacotherapies for Child Healthcare Clinicians | ||
---|---|---|
Dosing | Instructions | |
Nicotine Replacement Options | ||
Nicotine Patches (OTC) (Generic also available by prescription) | ||
15 mg 21 mg 14 mg 7 mg |
Initial 1 patch/16 hours MAX same Initial 1 patch/24 hours MAX same |
Treatment duration: 8 weeks. At the start of each day, place a fresh patch on a relatively hairless area of skin between the waist and neck. If sleep disruption occurrs, the patch may be worn only during waking hrs. |
Nicotine Gum (OTC) | ||
2 mg 4 mg |
Initial 1 piece/1-2 hrs MAX 24 pieces/24 hrs |
Treatment Duration: 8-12 weeks. Chew gum slowly until the taste of mint or pepper occurs. Then park the gum between the cheek and gum to permit absorbtion through the oral mucosa. Repeat and continue for approx. 30 min. Avoid acidic beverages (coffee, juice, soda) or eating for 15 minutes before and during use. |
Nicotine Nasal Spray (prescription) | ||
10 mg/ml | Initial 1-2 doses/hr MAX 5 doses/hr or 40 doses/day |
Treatment Duration: 3-6 mos. One spray to each nostril (1 mg total nicotine). Avoid sniffing, inhaling, or swallowing during administration as irritating effects are increased. Tilt the head back slightly during administration. |
Inhaler (prescription) | ||
10 mg/cartridge | Initial 6-16 cartridges/day MAX 16 cartridges/day |
Treatment Duration: 3-6 mos. Temperature < 40° F decrease nicotine delivery. Avoid acidic beverages or eating for 15 minutes before use. |
Lozenge (OTC) | ||
2 mg 4 mg |
1 loz/1-2 hrs (wks 1-6) 1 loz 2-4 hrs (wks 7-9> 1 loz 4-8 hrs (wks 10-12) |
Treatment Duration 12 wks. Avoid eating/drinking for 15 minutes before use. Suck lozenge until it dissolves. Do not bite, chew, or swallow lozenge. |
Non-Nicotine Medication | ||
Bupropion HCL SR (prescription) | ||
150 mg tablet | Initial 150 mg/day (days 1-3) 300 mg/day (day 4+) MAX 300 mg/day |
Treatment Duration 7-12 wks. Begin bupropion 1-2 wks before the quit date. Duration of therapy is 7-12 wks and may be extended up to 6 mos. |
Please consult the Physician's Desk Reference for comparable product information and contraindications |
Quick Guide to Tobacco Treatment The 5A's for Child Healthcare Clinicians |
---|
Ask about tobacco use at every visit |
|
Advise all tobacco users to quit |
|
Assess readiness to quit |
|
Assist tobacco users in quitting |
|
Arrange follow-up |
|
Bidis (pronounced "bee-dees") are small, thin hand-rolled cigarettes imported to the United States primarily from India and other Southeast Asian countries. They consist of tobacco wrapped in a tendu or temburni leaf (plants native to Asia), and may be secured with a colorful string at one or both ends. Bidis can be flavored (e.g., chocolate, cherry, and mango) or unflavored. They have higher concentrations of nicotine, tar, and carbon monoxide than conventional cigarettes sold in the United States.
Kreteks (pronounced "cree-techs") are sometimes referred to as clove cigarettes. Imported from Indonesia, kreteks typically contain a mixture consisting of tobacco, cloves, and other additives. As with bidis, standardized machine-smoking analyses indicate that kreteks deliver more nicotine, carbon monoxide, and tar than conventional cigarettes. There is no evidence to indicate that bidis or kreteks are safe alternatives to conventional cigarettes.
Yes! And not for the better.
No. The risk for lung cancer is only slightly lower with low tar cigarettes. Reduced tar levels have little, if any, effect on other lung diseases or heart disease. Existing research does not support recommending that smokers switch to low-yield cigarette brands. There is no convincing evidence that changes in cigarette design have resulted in an important decrease in the diseases caused by cigarettes. The best thing you can do for your health is to quit now.
There is no evidence to indicate that clove cigarettes, bidis or cigars are safe alternatives to conventional cigarettes.
Smokeless tobacco is a significant health risk and is not a safe substitute for smoking cigarettes.
Yes, smoking really hurts athletic performance. Here's how.
Nicotine is the psychoactive drug in tobacco products that produces dependence. Most smokers are dependent on nicotine, and smokeless tobacco use can also lead to nicotine dependence. Nicotine dependence is the most common form of chemical dependence in the United States. Research suggests that nicotine is as addictive as heroin, cocaine, or alcohol. Examples of nicotine withdrawal symptoms include irritability, anxiety, difficulty concentrating, and increased appetite. Quitting tobacco use is difficult and may require multiple attempts, as users often relapse because of withdrawal symptoms. Tobacco dependence is a chronic condition that often requires repeated intervention.
People who use telephone counseling are twice as likely to quit as people who don't get any counseling. Telephone counselors are trained to help quitters avoid common mistakes that might lead to relapse. Also most states offer some kind of free telephone counseling or a "Quitline" for people seeking to quit smoking. To find a Quitline in your area, call the American Cancer Society at 1-800-ACS-2345.
A recent comprehensive review of adolescent smoking cessation programs indicated that classroom programs had the highest cessation rates (17%), followed by computer-based programs (13%) and school-based clinics (12%).
Brief office based interventions, such as videos, in-person counseling, referrals to quitting support and diligent follow-up, can also boost an adolescents chances of quitting.
Yes. Medication almost doubles a person's chances of quitting and quitting for good.
All five of the FDA-approved medications for smoking cessation are recommended including bupropion SR, nicotine gum, nicotine inhaler, nicotine nasal spray, and the nicotine patch.
But because of the lack of sufficient data to rank-order these five medications, choice of a specific first-line medication must be guided by factors such as clinician familiarity with the medications, contraindications for selected patients, patient preference, previous patient experience with a specific pharmacotherapy (positive or negative), and patient characteristics (e.g., history of depression, concerns about weight gain).
Special consideration should be given before using medication with selected populations: those with medical contraindications, those smoking less than 10 cigarettes/day, pregnant, and adolescent smokers.
If medication is used with lighter smokers, clinicians should consider reducing the dose of first-line medications.
Clonidine and nortriptyline. Consider prescribing these second-choice agents for patients unable to use first-choice medications because of contraindications or for patients for whom first- choice medications are not helpful. Monitor patients for the known side effects of second- choice agents.
Bupropion SR and nicotine replacement therapies (NRTs), in particular nicotine gum, have been shown to delay, but not prevent, weight gain.
Bupropion SR and nortriptyline appear to be effective with this population.
Yes. This approach may be helpful with smokers who report persistent withdrawal symptoms during the course of pharmacotherapy or who desire long-term therapy. A minority of individuals who successfully quit smoking use over-the-counter nicotine replacement medications (gum, nasal spray, inhaler) long-term. The use of these medications long-term does not present a known health risk. Additionally, the FDA has approved the use of bupropion SR for a long-term maintenance indication.
Yes. There is evidence that combining the nicotine patch with either nicotine gum or nicotine nasal spray increases long-term abstinence rates over those produced by a single form of NRT.
To find the comment in-context, please follow the provided links.